Stockscreener 앱 받기
23.68
4.05%
-1.00
시간 외 거래:
23.75
0.07
+0.30%
10 X Genomics Inc 주식(TXG)의 최신 뉴스
TXG News | 10X GENOMICS INC-CLASS A (NASDAQ:TXG) - ChartMill
10x Genomics, Inc.Common Stock (NQ: TXG - FinancialContent
10X Genomics’ SWOT analysis: stock faces profitability test - Investing.com
The 5 Most Interesting Analyst Questions From 10x Genomics’s Q1 Earnings Call - Yahoo Finance
10x Genomics Q1 earnings call highlights - MSN
The Bull Case For 10x Genomics (TXG) Could Change Following Mixed Q1 Results And Reaffirmed Guidance - Sahm
Precision Trading with 10x Genomics Inc. (TXG) Risk Zones - Stock Traders Daily
TXG Technical Analysis & Stock Price Forecast - Intellectia AI
10x Genomics seen as key player in AI-driven biological data buildout - MSN
Analysts Are Updating Their 10x Genomics, Inc. (NASDAQ:TXG) Estimates After Its First-Quarter Results - Sahm
QUADRANT CAPITAL GROUP LLC's 10x Genomics Inc(TXG) Holding History - GuruFocus
Why 10x Genomics (TXG) Stock Is Down Today - Yahoo Finance
10x Genomics Inc (TXG) Stock Price, Trades & News - GuruFocus
10x Genomics settles suit with rival and targets DNA sequencing startup - Life Sciences Intellectual Property Review
This $4 Million Bet Shows Growing Confidence in 10x Genomics as Stock Surges 116% - Yahoo Finance
This $4 Million Bet Shows Growing Confidence in 10x Genomics as Stock Surges 116% - The Motley Fool
10x Genomics (NASDAQ:TXG) Price Target Raised to $20.00 at JPMorgan Chase & Co. - MarketBeat
Morgan Stanley Lifts Price Target on 10x Genomics to $22 From $20, Keeps Equalweight Rating - Moomoo
10x Genomics Q1 Earnings Call Highlights - sharewise.com
MSN Money - MSN
10x, Curio Settle Genomics Patent Suit Before Trial - Law360
10x, Harvard Sue Sequencing Co. Over Biology Patents - Law360
Harvard, 10x Patent Suit Targets Newer Cell-Mapping Platform - Bloomberg Law News
10x Genomics Q1 Earnings & Revenues Beat Estimates, Gross Margin Up - TradingView
Deutsche Bank Adjusts 10x Genomics Price Target to $23 From $17, Maintains Hold Rating - Moomoo
TXG Financials: Income Statement, Balance Sheet & Cash Flow | 10X Genomics, Inc. - Stock Titan
BofA Securities Maintains 10x Genomics(TXG.US) With Hold Rating, Maintains Target Price $30 - Moomoo
10X GENOMICS ($TXG) Releases Q1 2026 Earnings - Moomoo
10x Genomics, Inc. (NASDAQ:TXG) Q1 2026 Earnings Call Transcript - Insider Monkey
Transcript : 10x Genomics, Inc., Q1 2026 Earnings Call, May 07, 2026 - marketscreener.com
10x Genomics, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
10x Genomics (TXG) Reports Q1 Loss, Beats Revenue Estimates - sharewise.com
10x Genomics (TXG) Q1 2026 Earnings Transcript - The Globe and Mail
10X Genomics Inc reports results for the quarter ended March 31Earnings Summary - TradingView
10x Genomics (TXG) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
10x Genomics (NASDAQ: TXG) boosts Q1 2026 margins on consumables growth - Stock Titan
10x Genomics (NASDAQ:TXG) Beats Q1 Estimates But Falls as Revenue Shrinks Year-Over-Year - ChartMill
Earnings Flash (TXG) 10x Genomics, Inc. Reports Q1 Revenue $150.8M, vs. FactSet Est of $146.4M - marketscreener.com
10x Genomics (TXG) Stock Falls on Q1 2026 Earnings - Quiver Quantitative
10x Genomics: Q1 Earnings Snapshot - kens5.com
Q1 2026 10X Genomics Inc Earnings Call Transcript - GuruFocus
10x Genomics’s (NASDAQ:TXG) Q1 CY2026: Beats On Revenue But Stock Drops - Yahoo Finance
10x Genomics Reports First Quarter 2026 Financial Results - PR Newswire
10x Genomics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Q1 2026: 10x Genomics (NASDAQ: TXG) narrows loss, launches Atera - Stock Titan
10X Genomics faces earnings test as AI promise meets funding reality By Investing.com - Investing.com Australia
10X Genomics faces earnings test as AI promise meets funding reality - Investing.com Nigeria
0.66%
자본화:
|
볼륨(24시간):